Each year, more than 5 million people worldwide are affected by a snakebite, resulting in 150,000 deaths, and 400,000 amputations. The current medical treatment against envenoming is based on the administration of an animal-derived antiserum, containing antibodies against snake venom toxins. Due to the heterologous and immunogenic nature of antivenom, patients in up to 80% of the cases experience serum sickness and anaphylaxis, which in some cases leads to death.
|Number of pages||1|
|Publication status||Published - 2016|
|Event||Symposium for Biological and Life Science Students (SymBLS) 2016 - Cambridge, United Kingdom|
Duration: 25 Nov 2016 → 25 Nov 2016
|Conference||Symposium for Biological and Life Science Students (SymBLS) 2016|
|Period||25/11/2016 → 25/11/2016|